SARS-CoV-2 Nucleocapsid Protein Antibody

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2/COVID-19) Nucleocapsid Protein (NP) Antibody is a chimaeric recombinant Monoclonal Antibody expressed in CHO cells against SARS-CoV-2/COVID-19 NP, containing Mouse variable region and Human IgG1 constant region.

The SARS-CoV-2 Nucleoprotein (also known as Nucleocapsid Protein or N Protein) is a protein that binds to the RNA in the viral particle. Changes to two amino acids in the nucleoprotein are thought to contribute to the virus’ ability to infect humans; this mutation allows the virus to reduce the binding capability of an HLA-C allele found in many Europeans. The nucleoprotein is the second most-common protein in SARS-CoV-2 targeted by the immune system, after the spike protein.

Target	Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Nucleocapsid Protein
Clonality	Monoclonal
Reactivity	Virus
Origin	Human
Expression	Recombinant
Tested Applications	ELISA, WB
Host	Human, Mouse
Recommended dilutions	ELISA: 1/5000 - 1/10,000, WB: 1/1000 - 1/2000. Optimal dilutions/concentrations should be determined by the end user.
Conjugation	Unconjugated
Immunogen	Recombinant SARS-CoV-2 Nucleocapsid Protein
Isotype	IgG1
Form	Liquid
Purification	Purified by affinity chromatography.
Storage	Aliquot and store at -20 °C. Avoid repeated freeze/thaw cycles.
Tag	Fc tag
Buffer	PBS, pH 7.5.
Concentration	2.13 mg/ml
Availability	Shipped within 5-10 working days.
Note	This product is for research use only.

Research Articles on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Nucleocapsid Protein

Write a review

Your Name

Your Email Address

PMID

DOI

Your Review

Rating

Continue